<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="5356">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03037216</url>
  </required_header>
  <id_info>
    <org_study_id>2016-34</org_study_id>
    <nct_id>NCT03037216</nct_id>
  </id_info>
  <brief_title>Investigation of Exercise Training-Induced Myokines and Adipolkines in Humans</brief_title>
  <official_title>Investigation of Exercise Training-Induced Myokines and Adipolkines in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Joslin Diabetes Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Daiichi Sankyo International</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Joslin Diabetes Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to find out whether exercise training leads to changes in the
      blood that are produced by exercised muscles and if these changes produce new hormones that
      affect the body's regulation of sugar and body weight.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 15, 2016</start_date>
  <completion_date type="Anticipated">July 1, 2017</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Single Group Assignment</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in circulating proteins in the blood.</measure>
    <time_frame>Baseline vs. Post 10 Week Training.</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Experimental Exercise-Training Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will undergo a 10-week aerobic exercise protocol.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise Intervention</intervention_name>
    <description>10 Week aerobic exercise training</description>
    <arm_group_label>Experimental Exercise-Training Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Age between 18-35. Body mass index (BMI) must be ≥18.5 and ≤26 kg/m2. HbA1c values ≤5.7%

        Exclusion Criteria:

          -  Age &lt;18 and &gt;50

          -  HbA1c ≥ 5.7%; heart or lung disease

          -  acute systemic infection accompanied by fever, body aches, or swollen lymph glands

          -  BMI ≥ 27 kg/m2

          -  current dieting or weight loss efforts

          -  current pregnancy or breastfeeding

          -  known history of HIV/AIDS; cancer

          -  biochemical evidence of renal or hepatic dysfunction; renal or liver disease
             demyelinating diseases such as multiple sclerosis or amyotrophic lateral sclerosis

          -  recent blood donation

          -  clinical history of stroke

          -  hypertension (systolic &gt; 140 mmHg or diastolic &gt; 90 mmHg)

          -  type 1 or 2 diabetes; inability to exercise at 50% of predicted heart rate (HR)
             reserve at baseline

          -  Participants taking beta-blockers Participants who screen positive for The American
             Heart Association's contraindications to exercise testing
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laurie J Goodyear, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Joslin Diabetes Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jeffrey J Richard, MS</last_name>
    <phone>6173094378</phone>
    <email>exercise.research@joslin.harvard.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Joslin Diabetes Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 27, 2017</lastchanged_date>
  <firstreceived_date>January 26, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Exercise</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
